Gerard P. Quinn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gerard P. Quinn has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Simon S. McDade
Queen's University Belfast
40 shared publications - Christopher J. Scott
The Patrick G Johnston Centre for Cancer Research, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7AE, United Kingdom
39 shared publications - Ewa K. Stachowiak
Department of Pathology and Anatomical Sciences, University at Buffalo, State University of New York, Buffalo, New York
39 shared publications - Joseph A. Spernyak
Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, USA
39 shared publications - Martin Clynes
Dublin City University
39 shared publications - Michal K. Stachowiak
Department of Biomedical Engineering, University at Buffalo, Buffalo, 14260, USA
39 shared publications
Latest Publications
- 18 August 2026
- Published by Edward Elgar Publishing
- p. 113-130
Breaking the link between poverty and disability: re-purposing human rights in the 21st century
- 18 August 2026
- Published by Edward Elgar Publishing
- p. 113-130
Breaking the link between poverty and disability: re-purposing human rights in the 21st century
- Open Access
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Table S6. Results of transcription factor enrichment analysis of PDX tumor #18269
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Table S6. Results of transcription factor enrichment analysis of PDX tumor #18269
- Open Access
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Table S3. Genes differentially expressed by sHHi treatment in SHHi-responder PDX #18269
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Table S3. Genes differentially expressed by sHHi treatment in SHHi-responder PDX #18269
- Open Access
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Figure S2. SHHi-treatment decreases tumor collagen and enhances SSL-DiI permeability and deposition
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Figure S2. SHHi-treatment decreases tumor collagen and enhances SSL-DiI permeability and deposition
- Open Access
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Figure S8. Correlation of FGFR1 expression with EMT marker expression in PDAC patient tumors
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Figure S8. Correlation of FGFR1 expression with EMT marker expression in PDAC patient tumors
- Open Access
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Figure S1. Histological and growth characteristics of PDAC PDXs
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Figure S1. Histological and growth characteristics of PDAC PDXs
- Open Access
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Figure S6. Analysis of transcription factor and master regulator enrichment of differentially expressed genes predict kinase-driven transcriptional changes in SHHi-treated tumors
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Figure S6. Analysis of transcription factor and master regulator enrichment of differentially expressed genes predict kinase-driven transcriptional changes in SHHi-treated tumors
- Open Access
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Table S5. Gene set enrichment analysis of genes differentially expressed in sHHi treated PDX #18269 based on GO annotations
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Table S5. Gene set enrichment analysis of genes differentially expressed in sHHi treated PDX #18269 based on GO annotations
- Open Access
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Table S5. Gene set enrichment analysis of genes differentially expressed in sHHi treated PDX #18269 based on GO annotations
- 1 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
Supplementary Table S5. Gene set enrichment analysis of genes differentially expressed in sHHi treated PDX #18269 based on GO annotations